CERT vs TMO · rev $385.1M vs P/E 24, rev $44.56B
Certara Inc (CERT) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CERT revenue for 2024-12-31 was $385.1M. Net income was -$12.1M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. CERT currently screens at market cap $1.86B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CERT currently screens at market cap $1.86B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CERT and TMO stock pages for the full models.
Not investment advice.